NCT00006062View on ClinicalTrials.gov

Oxaliplatin to Treat Advanced Cancers With Liver Dysfunction

PHASE1CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

July 31, 2000

Study Completion Date

May 31, 2001

Conditions
Liver Disease
Interventions
DRUG

oxaliplatin

Trial Locations (1)

20892

National Cancer Institute (NCI), Bethesda

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00006062 - Oxaliplatin to Treat Advanced Cancers With Liver Dysfunction | Biotech Hunter | Biotech Hunter